Your browser doesn't support javascript.
loading
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.
Matsoukas, John; Apostolopoulos, Vasso; Zulli, Anthony; Moore, Graham; Kelaidonis, Konstantinos; Moschovou, Kalliopi; Mavromoustakos, Thomas.
Afiliação
  • Matsoukas J; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
  • Apostolopoulos V; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Zulli A; NewDrug, P.C., Patras Science Park, 26504 Patras, Greece.
  • Moore G; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
  • Kelaidonis K; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
  • Moschovou K; Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.
  • Mavromoustakos T; NewDrug, P.C., Patras Science Park, 26504 Patras, Greece.
Molecules ; 26(3)2021 Jan 25.
Article em En | MEDLINE | ID: mdl-33504092
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiotensina II / Antagonistas de Receptores de Angiotensina / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiotensina II / Antagonistas de Receptores de Angiotensina / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article